Membranous staining with the RAS Q61R IHC was found to be 100% predictive of RET-negative germline testing, highlighting its potential role as an inexpensive and rapid modality to screen patients who will undergo RET germline testing for MTC. This evidence concerns the gene RET and medullary thyroid gland carcinoma.